| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥4369.8B | ¥4168.2B | +4.8% |
| Operating Income | ¥94.1B | ¥100.2B | -6.0% |
| Ordinary Income | ¥67.7B | ¥66.2B | +2.3% |
| Net Income | ¥44.4B | ¥63.2B | -29.8% |
| ROE | 4.2% | 6.3% | - |
FY2025 Q3 results: Revenue 436,977 million yen (YoY +4.8%), Operating Income 9,413 million yen (YoY -6.0%), Ordinary Income 6,769 million yen (YoY +2.3%), Net Income 4,441 million yen (YoY -29.8%). The company achieved top-line growth driven primarily by the Device BU segment, which expanded 4.6% YoY to 385,131 million yen. However, profitability deteriorated significantly at the bottom line due to elevated interest expenses of 2,134 million yen and foreign exchange losses of 777 million yen. Operating margin contracted to 2.2% from 2.4% in the prior year, while net profit margin compressed sharply to 1.0% from 1.5%. The substantial decline in net income despite revenue growth reflects structural profitability challenges including low gross margin of 8.3%, increased financial costs from higher short-term borrowings, and elevated tax burden with an effective tax rate of approximately 40%. Total assets increased 10.2% to 341,579 million yen, while equity grew 4.7% to 104,795 million yen, resulting in an equity ratio of 30.7%.
Revenue increased 4.8% YoY to 436,977 million yen, driven by growth across the Device BU and IT & Service BU segments. The Device BU, comprising Device and EMS sub-segments, generated revenue of 385,131 million yen (up 2.8% YoY), representing 88.1% of total revenue and serving as the core business. Within Device BU, the Device sub-segment recorded 367,790 million yen (up 4.7% YoY) while the EMS sub-segment declined to 17,340 million yen (down 25.7% YoY). The System BU generated 32,747 million yen (down 8.9% YoY), with System Solution at 19,322 million yen (down 3.1% YoY) and Eco Solution at 13,425 million yen (down 16.2% YoY). The IT & Service BU showed the strongest growth on a percentage basis, reaching 19,098 million yen (up 210.8% YoY), primarily driven by the consolidation of PCI Holdings acquired in the prior period.
On the profit side, operating income declined 6.0% to 9,413 million yen despite revenue growth, reflecting margin compression from 2.4% to 2.2%. Gross profit increased to 36,457 million yen with a gross margin of 8.3%, but SG&A expenses rose to 27,043 million yen (6.2% of revenue), constraining operating profitability. Ordinary income improved 2.3% to 6,769 million yen, but the gap between operating and ordinary income widened significantly due to non-operating factors including interest expenses of 2,134 million yen, foreign exchange losses of 777 million yen, and equity method investment losses of 193 million yen. Net income dropped 29.8% to 4,441 million yen as extraordinary losses of 449 million yen (primarily asset impairment of 156 million yen in Device BU) and a high effective tax rate of approximately 40% further compressed profitability. The company recorded a negative bargain purchase gain of 153 million yen in the prior year from the Dexerials Hong Kong acquisition, which did not recur. This represents a revenue up, profit down pattern, with structural challenges in converting top-line growth to bottom-line profitability due to low gross margins, elevated financial costs, and high tax burden.
The Device BU is the core business, generating 385,131 million yen in revenue (88.1% of total) and 8,290 million yen in segment profit. Within this segment, the Device sub-segment contributed 367,790 million yen in revenue with segment profit of 7,895 million yen, while the EMS sub-segment recorded 17,340 million yen in revenue and 395 million yen in profit. Segment profit margin for the combined Device BU was 2.2%, showing the lowest margin among reporting segments. The System BU generated 32,747 million yen in revenue with segment profit of 1,770 million yen, reflecting a 5.4% segment margin. System Solution recorded 19,322 million yen in revenue with profit of 72 million yen (0.4% margin), while Eco Solution achieved 13,425 million yen in revenue with profit of 1,698 million yen (12.6% margin), representing the highest margin business. The IT & Service BU contributed 19,098 million yen in revenue and 741 million yen in profit, with a segment margin of 3.9%. The Device BU experienced segment profit growth of 1.1% YoY despite revenue growth, indicating margin pressure, while System BU segment profit declined 43.6% YoY alongside the 8.9% revenue decline. Corporate adjustments of negative 1,388 million yen reduced consolidated operating income. The Device BU recorded fixed asset impairment losses of 156 million yen in the current period and goodwill of 1,082 million yen increased from business acquisitions by ViMOS Technologies (RESTAR FRAMOS Technologies) during Q3. Material margin disparity exists between segments, with Eco Solution's 12.6% margin substantially exceeding the Device BU's 2.2% margin, highlighting the low-margin characteristics of the core Device business.
[Profitability] ROE of 4.2% remains below the trading industry median of 6.4%, reflecting weak profitability from low margins and high financial costs. Operating margin of 2.2% declined from 2.4% in the prior year and falls below the industry median of 3.2%. Net profit margin compressed to 1.0% from 1.5% YoY, significantly below the industry median of 2.7%, due to elevated interest expenses, foreign exchange losses, and high tax burden. Gross margin of 8.3% indicates limited pricing power and a low-margin business model. [Cash Quality] Cash and deposits totaled 45,150 million yen, providing coverage of 0.65x against short-term borrowings of 69,991 million yen, indicating constrained liquidity despite absolute cash levels. Operating working capital turnover stands at approximately 126 days, above the industry median of 62 days, reflecting inefficient working capital management. [Investment Efficiency] Total asset turnover of 1.28 aligns with the industry median of 1.00, indicating relatively efficient asset utilization despite low margins. Receivables turnover extends to 113 days (DSO), substantially above the industry median of 79 days, suggesting collection challenges. Inventory turnover of 56 days remains within the industry interquartile range of 42 to 84 days. Payables turnover of 104 days exceeds the industry median of 78 days, indicating extended payment terms with suppliers. [Financial Health] Equity ratio of 30.7% falls significantly below the industry median of 46.4%, reflecting high leverage. Current ratio of 155.1% sits below the industry median of 188%, while remaining adequate for near-term liquidity. Debt-to-equity ratio of 2.26 exceeds the industry median of 2.13 and the 2.0 threshold typically associated with elevated financial risk. Interest coverage ratio of 4.41 times provides limited cushion, with interest expenses of 2,134 million yen representing a substantial fixed cost burden.
Cash and deposits increased 13.8% YoY to 45,150 million yen, though this growth lagged behind the 10.2% expansion in total assets. The company's cash position provides coverage of 0.65x against short-term borrowings of 69,991 million yen, which increased 33.2% YoY from 52,539 million yen, indicating growing refinancing risk. Working capital movements reflect operational challenges, with accounts receivable rising 19.1% to 135,447 million yen, outpacing the 4.8% revenue growth and signaling collection delays with DSO extending to 113 days. Inventories increased 13.8% to 61,048 million yen, growing faster than revenue and suggesting potential inventory buildup or slower turnover. Trade payables of 103,431 million yen provide natural financing, with payables days of 104 exceeding both receivables collection and inventory turnover cycles. The substantial increase in short-term borrowings compensated for working capital absorption and supported M&A activities, including the acquisition of ViMOS Technologies businesses during Q3 that generated 1,082 million yen in goodwill. Total liabilities expanded 13.5% to 236,784 million yen, with current liabilities representing 65.1% of total liabilities, concentrating maturity pressure in the near term. The balance sheet structure indicates that operating profit growth has not translated to proportional cash accumulation, with financial leverage increasing as reflected in the financial leverage ratio rising to 3.26 times.
Ordinary income of 6,769 million yen versus operating income of 9,413 million yen indicates non-operating net costs of approximately 2,644 million yen, representing a 28.1% reduction from operating to ordinary profit levels. Primary non-operating factors include interest expenses of 2,134 million yen, foreign exchange losses of 777 million yen, and equity method investment losses of 193 million yen, partially offset by interest and dividend income of 215 million yen. Non-operating costs represent 0.6% of revenue, with interest expenses alone consuming 0.5% of sales, reflecting the burden of elevated debt levels. The company recorded extraordinary losses of 449 million yen, including fixed asset impairment of 156 million yen in the Device BU segment. Profit before tax of 6,378 million yen faced an effective tax rate of approximately 40.5%, with income taxes of 2,584 million yen significantly reducing net income to 4,441 million yen. The high tax burden and substantial financial costs indicate earnings quality concerns, as operating profitability does not flow through efficiently to net income. Non-recurring items include the impairment charge and prior period's negative bargain purchase gain of 153 million yen that did not repeat. The wide gap between gross profit margin of 8.3% and operating margin of 2.2% demonstrates high SG&A intensity, while the further compression to net margin of 1.0% reflects financial leverage costs and tax burden that constrain earnings quality and sustainability.
The company maintains full-year guidance of revenue 600,000 million yen (YoY +7.0%), operating income 16,000 million yen (YoY +12.9%), ordinary income 12,500 million yen (YoY +30.8%), and net income 7,500 million yen. Q3 cumulative progress against full-year guidance shows revenue achievement of 72.8%, suggesting the company is slightly behind the standard 75% pace for nine-month results. Operating income progress of 58.8% (9,413 million yen vs. 16,000 million yen target) indicates significant fourth-quarter profit improvement is required to meet guidance, necessitating approximately 6,587 million yen in Q4 operating income compared to Q3 cumulative quarterly average of 3,138 million yen. Ordinary income progress of 54.2% similarly requires substantial Q4 performance improvement. Net income progress of 59.2% faces challenges from the current effective tax rate and financial cost structure. Achieving full-year guidance requires material improvement in operating margin from the current 2.2% to approximately 2.7% on a full-year basis, demanding either revenue acceleration, SG&A cost reduction, or gross margin enhancement in Q4. The guidance implies Q4 revenue of approximately 163,000 million yen, representing 27.2% of annual revenue, which would be elevated relative to typical quarterly distribution. Key assumptions embedded in the forecast include stabilization of foreign exchange impacts, continued integration benefits from M&A activities including PCI Holdings and ViMOS Technologies acquisitions, and operational efficiency gains. The below-pace progress, particularly in profitability metrics, suggests execution risk in achieving full-year targets without significant fourth-quarter operational improvements.
The company forecasts an annual dividend of 65.00 yen per share for the full fiscal year, representing an 8.3% increase from the prior year's 60.00 yen. Based on current nine-month net income of 4,441 million yen and average outstanding shares of 28,118 thousand, basic EPS stands at 134.92 yen, down 26.6% YoY from 183.80 yen. The forecasted dividend of 65.00 yen against full-year EPS guidance of 266.73 yen implies a payout ratio of 24.4% on a forward basis. However, comparing the forecasted annual dividend of 65.00 yen against the current nine-month trailing EPS of 134.92 yen yields an elevated implied payout ratio of 48.2%, which would rise substantially if full-year EPS falls short of guidance. The forecasted dividend represents a dividend yield calculation base of 65.00 yen per share. No share buyback activity was disclosed in the reporting period. The dividend policy appears committed to growth despite earnings volatility, with the 8.3% dividend increase contrasting against the 29.8% decline in net income. Given cash and deposits of 45,150 million yen against short-term debt of 69,991 million yen and annual dividend payments estimated at approximately 1,828 million yen (based on 28,118 thousand shares), dividend sustainability depends on operating cash flow generation and maintenance of credit facility access. The absence of disclosed operating cash flow data limits assessment of cash-based dividend coverage, though the combination of elevated working capital absorption, increased borrowings, and constrained cash-to-debt ratios suggests limited financial flexibility to support dividend growth if profitability does not improve.
Refinancing and liquidity risk from elevated short-term debt concentration. Short-term borrowings increased 33.2% YoY to 69,991 million yen, representing 65.1% of total liabilities and creating maturity concentration. Cash coverage of short-term debt stands at only 0.65 times, exposing the company to refinancing risk if credit market conditions tighten or operating cash flow deteriorates. The debt-to-equity ratio of 2.26 times exceeds the 2.0 threshold typically associated with elevated financial leverage, while interest coverage of 4.41 times provides limited cushion against earnings volatility.
Margin compression risk from low-margin business model and cost structure. Gross margin of 8.3% and operating margin of 2.2% rank below industry medians, indicating limited pricing power and high cost sensitivity. The Device BU core business operates at 2.2% segment margin, making profitability vulnerable to volume declines, price competition, or cost inflation. Interest expenses of 2,134 million yen represent 22.7% of operating income, meaning modest margin deterioration or interest rate increases could eliminate profitability. Foreign exchange exposure adds volatility, with 777 million yen in exchange losses in the current period.
Working capital management and cash conversion challenges. DSO of 113 days exceeds the industry median of 79 days by 43%, while operating working capital turnover of 126 days doubles the industry median of 62 days, indicating inefficient cash conversion. Accounts receivable grew 19.1% against 4.8% revenue growth, and inventories increased 13.8%, both outpacing sales and absorbing cash. Extended collection cycles and inventory buildup constrain free cash flow generation needed to service debt, fund dividends, and support growth investments including M&A integration.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: ROE 4.2% materially underperforms the trading industry median of 6.4% (2025-Q3, n=19), positioning the company in the lower performance quartile. Operating margin of 2.2% falls below the industry median of 3.2% (IQR: 1.7% to 4.9%, n=17), while net profit margin of 1.0% significantly trails the industry median of 2.7% (IQR: 1.3% to 6.0%, n=19). The company's Return on Assets of 3.4% aligns with the industry median of 3.4%, but Return on Invested Capital of 3.9% sits below typical industry levels.
Financial Health: Equity ratio of 30.7% ranks substantially below the industry median of 46.4% (IQR: 39.6% to 52.6%, n=19), indicating higher financial leverage. The debt-to-equity ratio of 2.26 times slightly exceeds the industry median of 2.13 times, while the current ratio of 155.1% falls short of the industry median of 188% (IQR: 164% to 238%, n=15). Net debt-to-EBITDA positioning cannot be precisely benchmarked due to the company's specific debt structure, though elevated short-term borrowings relative to cash suggests less conservative financial positioning than industry peers maintaining negative net debt positions.
Efficiency: Asset turnover of 1.28 times exceeds the industry median of 1.00 (IQR: 0.62 to 1.20, n=19), representing a relative operational strength. However, operating working capital turnover of 126 days substantially exceeds the industry median of 62 days (IQR: 39 to 112 days, n=18), indicating inferior working capital efficiency. Receivables turnover of 113 days extends beyond the industry median of 79 days (IQR: 67 to 103 days, n=18), while payables turnover of 104 days exceeds the industry median of 78 days (IQR: 63 to 98 days, n=17). Inventory turnover of 56 days performs favorably relative to the industry median of 56 days.
Growth: Revenue growth of 4.8% YoY aligns with the industry median of 5.0% (IQR: -5.0% to 7.8%, n=19), indicating market-rate expansion. However, EPS declined 26.6% YoY, contrasting sharply with the industry median EPS growth of 24% (IQR: 0% to 107%, n=19), reflecting the company's profitability challenges despite comparable top-line growth.
(Source: Proprietary analysis. Industry: Trading sector, N=19 companies, Comparison period: FY2025-Q3)
Revenue growth at industry-median pace fails to translate to profitability improvement, with net income declining 29.8% despite 4.8% revenue growth. This divergence stems from structural factors including 8.3% gross margin, elevated interest expenses consuming 22.7% of operating income, and a 40.5% effective tax rate. The company's profitability metrics (ROE 4.2%, operating margin 2.2%, net margin 1.0%) all trail industry medians by 2.2 percentage points, 1.0 percentage point, and 1.7 percentage points respectively, indicating below-average earnings power that compounds with high financial leverage.
Financial structure risk escalation warrants monitoring, with short-term borrowings increasing 33.2% to 69,991 million yen while cash coverage deteriorated to 0.65 times. The debt-to-equity ratio of 2.26 times combined with 65.1% short-term liability concentration creates refinancing sensitivity. Working capital inefficiency compounds liquidity pressure, as DSO of 113 days exceeds industry median by 43% and accounts receivable growth of 19.1% outpaces revenue growth by 4 times, suggesting collection deterioration or customer payment term extensions that absorb cash.
Full-year guidance achievement faces execution challenges, with nine-month operating income progress of 58.8% requiring approximately 6,587 million yen in Q4 operating profit to meet the 16,000 million yen target, representing double the quarterly run-rate achieved in the first nine months. Meeting guidance necessitates either substantial revenue acceleration to approximately 163,000 million yen in Q4 (27% of annual revenue) or material margin expansion from cost reduction, neither of which is clearly evidenced in current trends. M&A integration benefits from PCI Holdings and ViMOS Technologies acquisitions present potential upside but also carry execution risk and goodwill impairment exposure, as demonstrated by the 156 million yen impairment charge in Device BU during the current period.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.